Terminal alkenes are easily derivatized, making them desirable functional group targets for polyketide synthase (PKS) engineering. However, they are rarely encountered in natural PKS systems. One mechanism for terminal alkene formation in PKSs is through the activity of an acyl-CoA dehydrogenase (ACAD). Herein, we use biochemical and structural analysis to understand the mechanism of terminal alkene formation catalyzed by an ACAD from the biosynthesis of the polyketide natural product FK506, TcsD. We show that, while TcsD is homologous to canonical α,β-ACADs, it acts regioselectively at the γ,ẟ-position and only on α,βunsaturated substrates. Furthermore, this regioselectivity is controlled by a combination of bulky residues in the active site and a lateral shift in the positioning of the FAD cofactor within the enzyme. Substrate modeling suggests that TcsD utilizes a novel set of hydrogen bond donors for substrate activation and positioning, preventing dehydrogenation at the α,β position of substrates. From the structural and biochemical characterization of TcsD, key residues that contribute to regioselectivity and are unique to the protein family were determined and used to identify other putative γ,ẟ-ACADs that belong to diverse natural product biosynthetic gene clusters. This work exemplifies a powerful approach to understanding unique enzymatic reactions and will facilitate future enzyme discovery, inform enzyme engineering, and aid natural product characterization efforts.
Introduction
Natural products often have complex chemical structures which can confer potent biological activity. Evolution selects for the diversification of these secondary metabolites, making natural product biosynthetic pathways rich resources for the discovery of both lead compounds for drug discovery and also enzymes with unique functions. [1] [2] [3] Next-generation sequencing has led to the identification of numerous biosynthetic gene clusters (BGCs), but the pool of "orphan" BGCs (i.e. BGCs with no cognate natural product identified) remains largely untapped. Predicting natural product structures from primary DNA sequence is challenging, as the in silico functional annotation of enzymes within BGCs is limited. Amino acid sequence homology can suggest a general function, but without in depth structural and biochemical characterization of one or more members of an enzyme family, precise predictions of the final natural product structure are difficult. The identification of specificity-conferring motifs in polyketide synthase (PKS) acyltransferase (AT) and ketoreductase (KR) domains, for example, has allowed for more precise predictions of final polyketide natural product structure, including the identity of the alkyl substituents incorporated by (AT) and final stereochemical outcome (KR) of a given PKS module. 4 While much effort has been dedicated to elucidating signature motifs within PKS domains, many PKS-associated enzymes that generate less common functional groups (such as non-canonical starter and extender units) are not as well annotated or understood. Better characterization of the enzymes implicated in the biosynthesis of unique and reactive moieties would facilitate the engineering of novel polyketides with applications in medicine, in agriculture, or as commodity chemicals. 1, 5, 6 One particular moiety of interest for PKS engineering is the alkene, as alkenes could easily be chemically derivatized to introduce a multitude of other desirable functionalities into a natural product. Alkenes are often generated within a polyketide via the action of reductive domains, but they are sequestered within the polyketide backbone and are therefore less sterically accessible for chemical modification than terminal alkenes. 7 There are few known examples of polyketides that contain terminal alkenes, including FK506, haliangicin, curacin A, and tautomycetin ( Figure 1A ). [8] [9] In curacin A, a terminal alkene is generated through a unique off-loading mechanism involving a sulfotransferase (ST) and thioesterase domain. 10 The tautomycetin terminal alkene is known to be formed after the chain has been released from the PKS but the process has yet to be fully characterized. 11, 12 A different mechanism for terminal alkene formation occurs via the action of an acyl-CoA dehydrogenase (ACAD) that oxidizes the γ,δ-position of a fatty acyl-CoA or acyl carrier protein (ACP), as observed in the haliangicin and FK506 pathways. 13, 14 The identification of other terminal alkene-forming ACADs is difficult, though, because of the enzymes' homology to canonical ACADs. Thus, identifying important sequence motifs is critical to more accurate annotation. ACADs are oxidoreductase flavoenzymes well known for catalyzing the first oxidative step of fatty acid β-oxidation: the dehydrogenation of saturated fatty acyl-Coenzyme A (CoA) thioesters to form the corresponding α,β-unsaturated product ( Figure 1B ). 15 The ACADs from the haliangicin and FK506 biosynthetic pathways, however, oxidize the γ,ẟ-position of a substrate. In order to facilitate better annotation of γ,ẟ-ACADs and, in turn, the identification of polyketide natural products that potentially contain terminal alkenes, a better functional characterization of γ,ẟ-ACADs is necessary. Herein, we report on our studies of the basis for the shift in regiochemistry of one of these unusual ACADs, TcsD, which forms the terminal alkene of the allylmalonyl-CoA extender unit in the biosynthesis of the polyketide FK506. 14 The allylmalonyl-CoA biosynthetic pathway was initially proposed as a hybrid PKS-fatty acid synthase (FAS) pathway in which a free-standing ketosynthase, TcsB, first condenses a propionate group with a malonyl-CoA-derived extender unit selected by the AT domain of TcsA to form 3-oxo-pentanoyl-TcsA ( Figure 1C , upper pathway). 14 After reduction by the producing organism's FAS, it was proposed that the final two enzymes TcsC (a crotonyl-CoA reductase) and TcsD (an ACAD) work interchangeably to convert 2-pentenoyl-TcsA to allylmalonyl-TcsA, with TcsD forming the unique terminal alkene moiety (lower pathway).
The sequence homology that TcsD shares with other ACADs suggests that it utilizes the same chemical mechanism to form the γ,ẟ-alkene of the allyl functional group. ACADs employ a catalytic base, typically a glutamate residue, to deprotonate the acidic α-proton of a fatty acyl-CoA substrate. 15 The concomitant transfer of a hydride from the β-carbon of the substrate to FAD results in the formation of an α,β-unsaturated product and the reduced flavin, FADH2. The reaction is mediated by pKa perturbations of both the catalytic glutamate residue and the substrate α-protons that occur within the active site of the enzyme. The pKa of the glutamate is raised from ~6 to ~9 due to desolvation of the active site upon the binding of a hydrophobic substrate, while the substrate protons are activated via hydrogen bonds of the substrate thioester carbonyl group with the amide backbone of the glutamate and the 2'-hydroxyl group of FAD. While this mechanism of substrate activation is plausible for the γ-protons of a substrate such as 2-pentenoyl-TcsA (which contains an α,β-alkene that can propagate electronic effects from the thioester to the γ-carbon), the activation of propylmalonyl-TcsA and its conversion to allylmalonyl-TcsA (pathway A2) is highly unlikely due to the aliphatic nature of the substrate.
Here we interrogate the activity of TcsD on both potential substrates and show that pathway B is the only route of allylmalonyl-ACP formation. Additionally, we show that TcsD oxidizes only α,β-unsaturated substrates and is regioselective for the γ,ẟ position of these substrates. Further, we present a high resolution TcsD crystal structure and propose a structural mechanism by which it exhibits precise regiocontrol over this transformation. Combined structural and biochemical analyses of this enzyme revealed signature residues that contribute to its unique regioselectivity. A better understanding of this unique enzyme's activity will not only inform the characterization of homologs and their associated BGCs, but the insights gained herein can also aid future enzyme engineering efforts.
Results and Discussion

Development of a biochemical activity assay for TcsD
In order to understand the mechanisms underlying TcsD activity, we initially sought to determine the native substrate(s) of the enzyme by biochemically interrogating both pathway B1
and A2 ( Figure 1C ). Therefore, we interrogated the activity of TcsD on its proposed ACP-bound substrates: 2-pentenoyl-ACP (pathway B1) and propylmalonyl-ACP (pathway A2). The substrates were incubated with TcsD in the presence of the external electron acceptor ferrocenium hexafluorophosphate to facilitate enzyme turnover. Assays were analyzed using targeted LC-MS/MS to monitor for the characteristic phosphopantetheine ejection transition ( Figure 2A ). 16 As expected, TcsD converted nearly all of the the 2-pentenoyl substrate to the corresponding 2,4-pentadienoyl-TcsA product, with no activity detected in boiled TcsD controls ( Figure 2B ). However, TcsD was unable to convert propylmalonyl-TcsA to allylmalonyl-TcsA under identical assay conditions ( Figure S1 ). We therefore concluded that the biosynthesis of 
Crystal structure of TcsD
The strict substrate specificity of TcsD suggested that there are structural elements within the enzyme's active site that control regioselectivity. To test this hypothesis, we obtained a crystal structure of TcsD, which was solved to 1.75Å resolution. The TcsD structure displays many similarities to those of other ACADs, such as the conserved ACAD fold consisting of a tetrameric quaternary structure, which is further organized into two sets of homodimers ( Figure   S7 ). Each monomer contains a single FAD cofactor and is composed of 3 subdomains consisting of a set of N-and C-terminal alpha helix domains that surround a middle beta sheet domain. The FAD cofactor adopts an extended conformation and is situated in a pocket formed by the C-terminal alpha helix domain, the middle beta sheet domain, and the C-terminal domain of the adjacent monomer.
The active site of TcsD also shares a similar overall organization with α,β-ACADs. Like the structures of the human, rat, and bacterial ACADs, the catalytic base of TcsD, Glu364, sits poised at the top of the active site pocket immediately above the fatty acyl binding chamber.
The back side of the pocket that bounds the fatty acyl binding region is shaped by the residue immediately upstream of the catalytic glutamate, Ile363, and three residues from helix 5: Phe79, Leu83, and Leu87 ( Figure 3B ). The FAD cofactor sits at the bottom of the active site, positioned below the Glu364 to facilitate planar electron transfer from the substrate.
Although similar in overall structure, TcsD possesses many features that distinguish it from canonical ACADs. The residues surrounding the TcsD active site entrance have diverged from the corresponding residues that are conserved in α,β-ACADs and contribute to the positioning of the adenosine portion of the coenzyme A substrate. TcsD does not possess the conserved Asp and Thr residues that form hydrogen bonds with the adenine base of Coenzyme A, nor the small helix between β-sheets 5 and 6 that often hydrogen bonds with the coenzyme A phosphate groups. The loop between sheets 5 and 6 in TcsD has instead been shortened.
Additionally, a short helix, helix 9, is present in the TcsD structure in a position that would collide with the adenine base of Coenzyme A as it is positioned in α,β-ACAD structures. While helix 9
in the TcsD structure seems to interfere with Coenzyme A binding, it is also present in the TcsD homolog from the haliangicin pathway, HliR, suggesting that this helix might contribute to the regiochemical shift observed in both enzymes ( Figure S8 ). 
Biochemical activity of TcsD mutants
In order to test whether the regioselectivity of TcsD is sterically controlled, a mutant of TcsD with a larger active site pocket that can accommodate a longer substrate is required.
Specifically, TcsD mutants that act upon a substrate with two additional carbons should also be able to bind pentanoyl-ACP in a manner that properly positions the α-and β-carbons within an accessible distance of Glu364 and FAD, respectively, as the α-carbon is two carbons removed from the γ-carbon. The residues that surround the active site of TcsD were therefore selectively mutated to alanines in order to enlarge the active site. Individual alanine mutants of Phe79, Leu83, Leu86, and Ile363 in addition to double mutants of neighboring residues (e.g.
L83A/L86A, F79A/L83A, and F79A/I363A but not F79A/L86A) were generated, and the dehydrogenation activity of mutants was then probed on a panel of α,β-unsaturated substrates.
The active site mutants were generally less active on 2-pentenoyl-ACP than the wild type enzyme ( Figure 3D ). However, the I363A and L83A mutants displayed nearly equal or equivalent activity to the wild type on 2-hexenoyl-ACP ( Figure 3E ). Proteins containing the L83A mutation were also active on the 2-heptenoyl-ACP substrate ( Figure 3F ). This indicates that Leu83 controls the chain length of the substrate.
After demonstrating that the active site of the L83A mutant had been enlarged to accommodate two additional carbons, we next probed its activity on 4-and 5-carbon fully saturated substrates to test if the enzyme was now capable of dehydrogenating the α,β-position in the absence of the wild type steric interactions. We found that the mutant enzyme was still inactive on butyryl-and pentanoyl-ACP (data not shown), suggesting that the observed regioselectivity is not controlled exclusively by steric interactions with the fatty acyl tail of a substrate.
Substrate modeling into TcsD active site
Given the retention of selectivity of the TcsD L83A mutant, we hypothesized that the Figure 4A ). We hypothesized that this would result in a concomitant shift in the positioning of the substrate thioester moiety.
In order to better understand how the change in FAD positioning affects substrate binding, we modeled a substrate analog consisting of a 2-pentenoyl thioester into the active site.
Initially, we positioned the thioester carbonyl oxygen within hydrogen bonding distance of both the 2'-OH of the FAD and the nitrogen of the amide bond of Glu364 ( Figure 4C ). Anchoring the carbonyl group in this location would force the substrate alkene into a cis conformation, as this is the only conformation that places the ẟ-carbon in close enough proximity to N5 of FAD.
However 
Genome mining reveals previously unidentified γ,δ-ACADs
After identifying the structural features that contribute to the unique regioselectivity of TcsD, we applied this mechanistic knowledge to find unidentified or misannotated γ,δ-ACADs among sequenced bacteria. In particular, we used the presence of bulky residues at positions corresponding to Phe79, Leu83, and Ile363 and helix 9 as requirements for the identification of γ,δ-ACADs. With these constraints, approximately 100 likely γ,δ-ACADs were identified using a combination of Hidden Markov Model (HMM), local sequence alignment (protein BLAST), and CORASON-BGC searches (Table S7) . [18] [19] [20] One feature in particular was strongly conserved across the putative γ,δdehydrogenases: the presence of helix 9, which we had identified as a unique feature in the TcsD structure ( Figure 5A and B) . The exact purpose of this loop remains unclear and will be the subject of further investigation. Additionally, we found that the presence of bulky residues at positions in the substrate acyl binding region were highly conserved across the group, with 98% of homologs displaying a Phe residue (2% Leu) and 96% displaying a Leu or Ile residue (4% Val) at the positions corresponding to Phe79 and Leu83 in TcsD ( Figure 5C ). The residues immediately preceding the catalytic glutamate (i.e. residue Ile363 in TcsD) were all bulky aliphatic residues as well (87% Val, 11% Ile, 2% Phe). However, bulky residues at this position are not unique to the identified γ,δ-ACADs as they are also observed in hydroxymalonate semialdehyde dehydrogenases such as FkbI.
Most of the TcsD homologs were associated with identifiable BGCs, although some were not located near any obvious secondary metabolite genes. The majority of the BGCassociated genes were located within type I PKS (T1PKS) clusters, but several were also identified within type II PKS (T2PKS) and NRPS clusters ( Figure 5D and S11). None of the newly-identified BGCs containing the putative γ,δ-ACADs have been experimentally characterized, but many show significant homology to known clusters (Table S7 ). Of the clusters that include putative γ,δ-ACADs, several contained proteins with homology to BGCs with known products, including the arsenopolyketides (T1PKS), oligomycin (T1PKS), E-837 (T1PKS), chlorothricin (T1PKS), butyrolactols (T1PKS), polyoxypeptin (T1PKS-NRPS), hedamycin (T2PKS), and erythrochelin (NRPS). Many of the homologous BGCs identified by antiSMASH have fatty acyl tails that could be potential substrates for γ,δ-ACADs in the uncharacterized clusters we identified.
Within the identified BGCs, analysis of the genomic contexts of the putative γ,δ-ACADs showed several patterns of syntenic genes ( Figure 5D and S11). The syntenic genomic regions can be grouped based on the type of gene cluster (e.g., probable butyrolactol or arsenopolyketide BGC) within which the putative γ,δ-ACADs occur. The groups of genes that are found near γ,δ-ACADs can also be used to postulate the enzymes' native substrates and even certain aspects of the molecular structure of the final natural product. The γ,δ-ACADs found in the erythrochelin-like gene clusters in Saccharothrix sp., for example, are consistently clustered with a free-standing ketosynthase (KS) and acyl carrier protein (ACP) pair ( Figure 5D ).
It is plausible that the KS domain forms a 5 carbon ACP-bound substrate upon which the γ,δ-ACAD can act after it is reduced to a 2-pentenoyl form. The genomic context of this and many of the other putative γ,δ-ACADs can be used to infer function and will inform future biosynthetic studies on the pathways and enzymes.
Conclusions
Terminal alkenes in polyketide natural products can be formed in several ways, including through the action of an acyl-CoA dehydrogenase. In this work we have described the biochemical and structural characterization of TcsD, the terminal alkene-forming γ,δ-ACAD from the biosynthesis of the allylmalonyl-CoA extender unit implicated in the biosynthesis of the polyketide FK506. We showed that TcsD acts on 2-pentenoyl-TcsA but not on propylmalonyl-
TcsA, suggesting that the bottom half of the allylmalonyl-CoA pathway proceeds only through pathways B1 and B2. TcsD only acts on 5-and 6-carbon α,β-unsaturated substrates and is regioselective for the γ,δ-position. This work exhibits how selective pressure causes enzymes to diverge not only at the amino acid sequence level, but also how it can result in significant shifts in protein structure to generate enzymes with divergent functions. Furthermore, it exemplifies how an understanding of the mechanisms employed by unique enzymes can be used as a means to refine the definitions of enzyme families and identify uncharacterized homologs. It will inform future efforts to characterize the identified homologs and the BGCs they residue within and can be used as a guide for the future discovery of natural products that contain terminal alkene handles. 
